Nicolaas Vlok - Dec 16, 2024 Form 4 Insider Report for MeridianLink, Inc. (MLNK)

Role
Chief Executive Officer, Director
Signature
/s/ Kayla Dailey, as Attorney-in-Fact
Stock symbol
MLNK
Transactions as of
Dec 16, 2024
Transactions value $
-$2,345,494
Form type
4
Date filed
12/18/2024, 04:18 PM
Previous filing
Dec 13, 2024
Next filing
Dec 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLNK Common Stock, par value $0.001 Options Exercise $397K +65.5K +6.28% $6.06 1.11M Dec 16, 2024 Direct F1
transaction MLNK Common Stock, par value $0.001 Sale -$1.47M -65.5K -5.91% $22.44 1.04M Dec 16, 2024 Direct F1, F2
transaction MLNK Common Stock, par value $0.001 Options Exercise $478K +78.9K +7.56% $6.06 1.12M Dec 17, 2024 Direct F1
transaction MLNK Common Stock, par value $0.001 Sale -$1.75M -78.9K -7.03% $22.19 1.04M Dec 17, 2024 Direct F1, F3
holding MLNK Common Stock, par value $0.001 29.8K Dec 16, 2024 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLNK Stock Option (option to buy) Options Exercise $0 -65.5K -3.08% $0.00 2.06M Dec 16, 2024 Common Stock, par value $0.001 65.5K $6.06 Direct F1, F5
transaction MLNK Stock Option (option to buy) Options Exercise $0 -78.9K -3.83% $0.00 1.98M Dec 17, 2024 Common Stock, par value $0.001 78.9K $6.06 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.08 to $22.61, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.01 to $22.34, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares are held directly by the Vlok Family Trust, dated March 17, 2009. The reporting person and his spouse are the co-trustees of the Vlok Family Trust, dated March 17, 2009 and share sole voting and dispositive power with respect to all securities held by such entity. The reporting person may be deemed to be the beneficial owner of the securities held by the Vlok Family Trust, dated March 17, 2009.
F5 With respect to (i) 912,500 of the shares underlying the option, one third of such shares vested on September 1, 2020, and the remaining two thirds of such shares vested in 24 equal monthly instalments thereafter, in each case subject to the reporting person's continued service through the applicable vesting date, (ii) 912,500 of the shares underlying this option vested upon the Company's level of achievement of a predetermined EBITDA metric, and (iii) 500,000 of the shares underlying this option vested immediately prior to the effectiveness of the Company's registration statement filed on form S-1 for its initial public offering.